Search Results
Nov 05, 2025, 07:04 ET RAMACO RESOURCES, INC. PRICES $300 MILLION CONVERTIBLE SENIOR NOTES OFFERING
Mine will be converted into mineral reserves in the future. Rare earth elements and critical minerals is a new initiative for us and, as such, has required and will continue to require us to make significant investments to build out our rare earth capabilities. Any forward-looking statement speaks only
More news about: Ramaco Resources, Inc.
Nov 05, 2025, 06:35 ET Rare Earth Magnets Market worth $30.01 billion by 2030 - Exclusive Report by MarketsandMarkets™
The automotive end-use industry is estimated to be the largest end-use industry of rare earth magnets in 2024. The automotive industry is increasingly employing rare earth magnets due to the rapid transition to electric and hybrid vehicles. These magnets, mainly NdFeB, are the
More news about: MarketsandMarkets
Nov 05, 2025, 06:35 ET Perrigo Reports Third Quarter 2025 Financial Results From Continuing Operations
to maturity; fluctuations in currency exchange rates and interest rates; receipt of potential earnout payments in connection with the sale of the HRA Rare Diseases Business and the risk that potential costs or liabilities incurred or retained in connection with this transaction may exceed our estimates
More news about: Perrigo Company plc
Nov 05, 2025, 06:30 ET Perrigo to Conduct Strategic Review of its Infant Formula Business
to maturity; fluctuations in currency exchange rates and interest rates; receipt of potential earnout payments in connection with the sale of the HRA Rare Diseases Business, and the sale of the Hospital and Specialty Business and the risk that potential costs or liabilities incurred or retained in connection
More news about: Perrigo Company plc
Nov 05, 2025, 06:00 ET Braveheart Bio Launches with $185M Series A Aiming to Transform Care of Hypertrophic Cardiomyopathy
overcontraction can lead to thickened heart muscle and declining performance in how well the heart fills with and pumps blood. HCM is among the most common rare diseases, affecting 1 in 500 people in the United States. BHB-1893 has undergone extensive clinical development, including a
More news about: Braveheart Bio
Nov 05, 2025, 05:01 ET Companion Diagnostics Market Worth USD 15.6 Bn by 2030 Growing at 12.4% CAGR, says Mordor Intelligence
CAGR of 12.42% during the forecast period (2025–2030). The market is primarily driven by the growing applications of precision medicine in oncology and rare diseases, and the increasing need for biomarker-based testing to improve drug efficacy and safety.
More news about: Mordor Intelligence Private Limited
Nov 04, 2025, 22:30 ET New Survey Finds Consumers Turn to Quora for Trusted Purchase Research
conversion. Unlike traditional social platforms, Quora attracts users who are actively researching products and brands, providing advertisers with a rare opportunity to engage audiences when purchase intent is at its peak. Quora's Strength in the Age of AI
More news about: Quora India
Nov 04, 2025, 20:06 ET FDA Issues Complete Response Letter for Biohaven's VYGLXIA (troriluzole) New Drug Application for Spinocerebellar Ataxia
efficacy, patients with rare diseases also deserve an efficient, fair and flexible regulatory process that aligns with the urgency of their high unmet medical needs. Such an approach has been mandated by Congress to empower the FDA with maximum regulatory flexibility for rare disease. As a company, we
More news about: Biohaven Ltd.
Nov 04, 2025, 17:31 ET Cholestatic Pruritus Market is Predicted to Exhibit Remarkable Growth at a CAGR of 23.4% in the US During the Forecast Period (2025-2034) | DelveInsight
in the US was estimated at USD 300 million in 2024. Cholestatic pruritus posed a significant clinical burden across rare liver diseases in the US in 2024, with approximately 76,000 cases in PBC. The overall burden of PBC, PSC, PFIC, ALGS,
More news about: DelveInsight Business Research, LLP
Nov 04, 2025, 17:07 ET RAMACO RESOURCES, INC. ANNOUNCES PROPOSED OFFERING OF BORROWED CLASS A COMMON STOCK TO FACILITATE HEDGING TRANSACTIONS
Mine will be converted into mineral reserves in the future. Rare earth elements and critical minerals is a new initiative for us and, as such, has required and will continue to require us to make significant investments to build out our rare earth capabilities. Any forward-looking statement speaks only
More news about: Ramaco Resources, Inc.
Nov 04, 2025, 17:05 ET RAMACO RESOURCES, INC. ANNOUNCES PROPOSED CONVERTIBLE SENIOR NOTES OFFERING
Mine will be converted into mineral reserves in the future. Rare earth elements and critical minerals is a new initiative for us and, as such, has required and will continue to require us to make significant investments to build out our rare earth capabilities. Any forward-looking statement speaks only
More news about: Ramaco Resources, Inc.
Nov 04, 2025, 17:02 ET Pearl Diver Credit Company Inc. Declares Monthly Dividends
an issuer, it has developed close relationships with over 80 CLO managers – and their analysts – across the CLO spectrum, enabling the firm to have rare access to critical credit information on underlying companies in CLO portfolios while avoiding conflicts of interest that might arise in performing
More news about: Pearl Diver Credit Company Inc.
Nov 04, 2025, 16:05 ET Viking Therapeutics to Participate at Upcoming Investor Conferences
of internally developed dual amylin and calcitonin receptor agonists (or DACRAs) for the treatment of obesity and other metabolic disorders. In the rare disease space, Viking is developing VK0214, a novel, orally available, small molecule selective thyroid hormone receptor beta agonist for the potential
More news about: Viking Therapeutics, Inc.
Nov 04, 2025, 16:01 ET AMGEN REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS
competition, as biosimilars have launched in the U.S. market. Rare Disease TEPEZZA
More news about: Amgen
Nov 04, 2025, 16:01 ET PTC Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results
biopharmaceutical company dedicated to the discovery, development and commercialization of clinically differentiated medicines for children and adults living with rare disorders. PTC is advancing a robust and diversified pipeline of transformative medicines as part of its mission to provide access to best-in-class
More news about: PTC Therapeutics, Inc.
Nov 04, 2025, 15:00 ET RightMove Health Appoints Joe Leinbach CEO to Accelerate National Growth in Value-Based MSK Care
sale to UHG; previously with The Carlyle Group and Goldman Sachs. "Joe brings a rare combination of operational depth and proven ability to scale value-based care models in partnership with leading health plans," said Frist. "With
More news about: RightMove Health LLC
Nov 04, 2025, 13:00 ET Four Seasons Celebrates the Festive Season with Exceptional Moments of Genuine Care
Hotel Jakarta – Liquid Gold Afternoon Tea: A Honeyed Ritual – La Patisserie enchants teatime with confections artfully prepared from rare Indonesian honeys, celebrating sustainable beekeeping and golden indulgence.
More news about: Four Seasons Hotels and Resorts
Nov 04, 2025, 12:11 ET Leading Charitable Fundraising Platform Charitybuzz Partners with Change to Fuel their Next Phase of Growth
shop, sweepstakes, and private client services, Charitybuzz transforms cultural capital into meaningful impact, spanning luxury travel, rare collectibles, and VIP access across entertainment, business, sports, and culture. Charitybuzz has partnered with leading organizations
More news about: Change
Nov 04, 2025, 12:08 ET Absolute Luxury: 73+ Acre Aspen Area Riverfront Ranch, Selling at Absolute Auction -- No Reserve
DeCaro Auctions International. "Large parcels with river frontage are extraordinarily rare, and with no reserve, buyers have the unique chance to name their price." A Rare Aspen Opportunity Properties of this scale
More news about: DeCaro Auctions International
Nov 04, 2025, 12:07 ET Freeman's | Hindman Rebrands as Freeman's
The series features the surprising -- decommissioned World War I battleships, Philadelphia's 19th-century Post Office building, and a rare copy of the Declaration of Independence found in a bookshop attic -- as well as the sublime, including luminous master works by Vincent Van
More news about: Freeman's Auction
Nov 04, 2025, 12:00 ET Lumati Appoints Investor and Visionary Leader Ruta Laukien As Executive Director and Chairwoman of the Board of Directors to Accelerate Mission of Impacting 1 Billion Lives by 2035
appointment of Ruta Laukien as the Executive Director and Chairwoman of the Board of Directors and the expansion of its investor group. Ruta brings a rare blend of financial acumen, operational leadership, and a passion for nature, adventure, and longevity that deeply aligns with Lumati's mission to positively
More news about: Lumati
Nov 04, 2025, 11:24 ET Ruli.ai Raises $6M and Welcomes Former Pinterest GC Michele Lee to Advisory Board as It Redefines the Future of Legal Work
legal operations by embedding intelligence directly into the enterprise stack," says Wayne Hu, Partner, SignalFire. "Ruli executes this vision with a rare combination of technical depth and domain credibility. Their continuous legal intelligence model represents exactly the kind of defensible, data-centric
More news about: Ruli.ai
Nov 04, 2025, 11:02 ET NEI Global Relocation Tops Trippel Survey as Companies Reevaluate Their Global Mobility Partners
gold standard in the mobility industry, drawing verified input directly from corporate mobility professionals and relocating employees. They offer a rare, objective view of how service providers perform under real-world conditions. "This data gives companies
More news about: NEI Global Relocation
Nov 04, 2025, 10:01 ET Global AI-Powered Pathology Market Valued at USD 184 Million in 2023, Set to Grow at 11.7% CAGR Through 2030 | Valuates Reports
prognostic assessments. This integration is expected to significantly enhance the predictive power of diagnostic systems and open new frontiers in cancer and rare-disease analysis. An increasing number of AI pathology solutions are receiving regulatory clearances from health authorities,
More news about: Valuates Reports
Nov 04, 2025, 09:00 ET TechSee Appoints Elizabeth Tobey as SVP of Marketing as It Expands Leadership in AI-Powered Customer Experience
an industry leader in CX AI, resulting in consistent year-over-year growth and widespread analyst recognition. "Elizabeth is a rare combination of visionary storyteller and results-driven growth leader," said Eitan Cohen, CEO of TechSee. "She has built and scaled iconic brands across
More news about: TechSee